Moderna MRNA shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program, helping ...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...
Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...
Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the March 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...
CHONGQING, CHINA - FEBRUARY 3: In this photo illustration, a smartphone displays the logo of Moderna, Inc. (NASDAQ: MRNA), a U.S.-based biotechnology company specializing in messenger RNA (mRNA) ...
The FDA reversed its decision on the company's flu vaccine application Pharma giant Moderna Inc (NASDAQ:MRNA) is enjoying a boost today, after the U.S. Food & Drug Administration (FDA) accepted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results